Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial

BACKGROUND: In stable patients with type 2 diabetes (T2D), insulin treatment is associated with elevated risk for major adverse cardiovascular events (MACE). Patients with acute coronary syndrome (ACS) and T2D are at particularly high risk for recurrent MACE despite evidence-based therapies. It is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Gregory G., Nicholls, Stephen J., Toth, Peter P., Sweeney, Michael, Halliday, Christopher, Johansson, Jan O., Wong, Norman C. W., Kulikowski, Ewelina, Kalantar-Zadeh, Kamyar, Ginsberg, Henry N., Ray, Kausik K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218391/
https://www.ncbi.nlm.nih.gov/pubmed/34158057
http://dx.doi.org/10.1186/s12933-021-01311-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218391/
https://www.ncbi.nlm.nih.gov/pubmed/34158057
http://dx.doi.org/10.1186/s12933-021-01311-9

Ejemplares similares